Familial Neuroblastoma
Published in Dongyou Liu, Handbook of Tumor Syndromes, 2020
Dongyou Liu
In addition, neuroblastoma may sometimes constitute part of cancer predisposition syndromes, including ROHHAD syndrome (rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysfunction, which overlaps clinically with CCHS but lacks PHOX2B mutation), RASopathies (e.g., Costello syndrome [HRAS mutation], Noonan syndrome [PTPN11, SOS1, KRAS, NRAS, RAF1, BRAF, MEK1, and RIT1 mutations], neurofibromatosis type 1 [NF1 mutation], Beckwith–Wiedemann syndrome [BWS, CDKN1C mutation], Li–Fraumeni syndrome [LFS, TP53 mutation], and hereditary pheochromocytoma/paraganglioma syndrome, etc.) [11–13]. However, genetic causes for about 15% of familial neuroblastoma cases have yet to be identified.